New quinazolinone‐based derivatives as DHFR/EGFR‐TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity-Reference-Cited by-同舟云学术

New quinazolinone‐based derivatives as DHFR/EGFR‐TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity

Published:2022-10-18 Issue:1 Volume:356 Page:2200417
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Archiv der Pharmazie

Author:

El‐Gazzar Yomna I.¹^ORCID,Ghaiad Heba R.²,El Kerdawy Ahmed M.³⁴,George Riham F.³,Georgey Hanan H.³⁵^ORCID,Youssef Khairia M.¹,El‐Subbagh Hussein I.⁶^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Future University in Egypt Cairo Egypt

2. Department of Biochemistry, Faculty of Pharmacy Cairo University Cairo Egypt

3. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Cairo University Cairo Egypt

4. Department of Pharmaceutical Chemistry, School of Pharmacy Newgiza University (NGU) Cairo Egypt

5. Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Drug Technology Egyptian Chinese University Cairo Egypt

6. Department of Medicinal Chemistry, Faculty of Pharmacy Mansoura University Mansoura Egypt

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.202200417

Reference61 articles.

1. Cancer statistics, 2022

2. Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services

3. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs

4. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent

5. Medicinal perspective of quinazolinone derivatives: Recent developments and structure–activity relationship studies

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel 2-substituted 2, 3-dihydroquinazolin-4(1H)-one derivatives as tubulin polymerization inhibitors for anticancer therapy: The in vitro and in vivo biological evaluation;European Journal of Medicinal Chemistry;2024-11

2. Synthesis, molecular modeling simulations and anticancer activity of some new Imidazo[2,1-b]thiazole analogues as EGFR/HER2 and DHFR inhibitors;Bioorganic Chemistry;2024-09

3. Unveiling the Therapeutic Potential of Quinazolinone Derivatives in Cancer Treatment: A Comprehensive Exploration;ChemistrySelect;2024-08-22

4. Dihydrofolate Reductase Inhibitors as Anticancer Agents: Progress and Perspectives in Drug Design and Development;Interdisciplinary Cancer Research;2024

5. Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR ^WT , EGFR ^T790M , and EGFR ^L858R );Journal of Enzyme Inhibition and Medicinal Chemistry;2023-08-07